This is not the most recent version of the article. View current version (18 JAN 2017)

Intervention Protocol

You have free access to this content

Effectiveness and safety of procalcitonin evaluation for reducing mortality in adult patients with sepsis, severe sepsis and septic shock

  1. Brenda NG Silva1,*,
  2. Régis B Andriolo2,
  3. Reinaldo Salomão3,
  4. Álvaro N Atallah1

Editorial Group: Cochrane Anaesthesia, Critical and Emergency Care Group

Published Online: 7 FEB 2014

DOI: 10.1002/14651858.CD010959


How to Cite

Silva BNG, Andriolo RB, Salomão R, Atallah ÁN. Effectiveness and safety of procalcitonin evaluation for reducing mortality in adult patients with sepsis, severe sepsis and septic shock (Protocol). Cochrane Database of Systematic Reviews 2014, Issue 2. Art. No.: CD010959. DOI: 10.1002/14651858.CD010959.

Author Information

  1. 1

    Centro de Estudos de Medicina Baseada em Evidências e Avaliação Tecnológica em Saúde, Brazilian Cochrane Centre, São Paulo, São Paulo, Brazil

  2. 2

    Universidade do Estado do Pará, Department of Public Health, Belém, Pará, Brazil

  3. 3

    Universidade Federal de São Paulo, Department of Medicine, São Paulo, São Paulo, Brazil

*Brenda NG Silva, Brazilian Cochrane Centre, Centro de Estudos de Medicina Baseada em Evidências e Avaliação Tecnológica em Saúde, Rua Borges Lagoa, 564 cj 63, São Paulo, São Paulo, 04038-000, Brazil. brendagomess@gmail.com.

Publication History

  1. Publication Status: New
  2. Published Online: 7 FEB 2014

SEARCH

This is not the most recent version of the article. View current version (18 JAN 2017)

References

Additional references

Adhikari 2010
Assunção 2010
  • Assunção M, Akamine N, Cardoso GS, Mello PV, Teles JM, Nunes AL, et al. Survey on physicians' knowledge of sepsis: do they recognize it promptly?. Journal of Critical Care 2010;25(4):545-52. [PUBMED: 20646902]
Azevedo 2012
  • Azevedo JR, Torres OJ, Czeczko NG, Tuon FF, Nassif PA, Souza GD. Procalcitonin as a prognostic biomarker of severe sepsis and septic shock. Revista do Colégio Brasileiro de Cirurgiões 2012;39(6):456-61. [PUBMED: 23348640]
Becker 2008
  • Becker KL, Snider R, Nylen ES. Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations. Critical Care Medicine 2008;36(3):941-52. [PUBMED: 18431284]
Bone 2009
  • Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 2009;136(5 Suppl):e28. [PUBMED: 20162763]
Chalupa 2011
  • Chalupa P, Beran O, Herwald H, Kaspříková N, Holub M. Evaluation of potential biomarkers for the discrimination of bacterial and viral infections. Infection 2011;39(5):411-7. [PUBMED: 21720792]
Christensen 2006
Cuthbertson 2013
  • Cuthbertson BH, Elders A, Hall S, Taylor J, Maclennan G, McKirdy F, et al. Mortality and quality of life in the five years after severe sepsis. Critical Care 2013;17(2):R70. [PUBMED: 23587132]
Dellinger 2013
  • Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock 2012. Intensive Care Medicine 2013;39(2):165-228. [PUBMED: 23361625]
Gendrel 1999
  • Gendrel D, Raymond J, Coste J, Moulin F, Lorrot M, Guérin S, et al. Comparison of procalcitonin with C-reactive protein, interleukin 6 and interferon-alpha for differentiation of bacterial vs. viral infections. The Pediatric Infectious Disease Journal 1999;18(10):875-81. [PUBMED: 10530583]
Guyatt 2008
  • Guyatt GH, Oxman AD, Kunz R, Vist GE, Falck-Ytter Y, Schunemann HJ. What is "quality of evidence" and why is it important to clinicians. British Medical Journal 2008;336(7651):995-8. [PUBMED: 18456631]
Higgins 2011
  • Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane-handbook.org.
Hingorani 2013
  • Hingorani AD, Windt DA, Riley RD, Abrams K, Moons KG, Steyerberg EW, et al. PROGRESS Group. Prognosis research strategy (PROGRESS) 4: stratified medicine research. BMJ 2013;346:e5793. [PUBMED: 23386361]
Hosein 2011
Jawad 2012
  • Jawad I, Lukšić I, Rafnsson SB. Assessing available information on the burden of sepsis: global estimates of incidence, prevalence and mortality. Journal of Global Health 2012;2(1):10404. [PUBMED: 23198133]
Karlsson 2009
  • Karlsson S, Ruokonen E, Varpula T, Ala-Kokko TI, Pettilä V, Finnsepsis Study Group. Long-term outcome and quality-adjusted life years after severe sepsis. Critical Care Medicine 2009;37(4):1268-74. [PUBMED: 19242321]
Kenzaka 2012
  • Kenzaka T, Okayama M, Kuroki S, Fukui M, Yahata S, Hayashi H, et al. Use of a semiquantitative procalcitonin kit for evaluating severity and predicting mortality in patients with sepsis. International Journal of General Medicine. 2012;5:483–8. [PUBMED: 22701089]
Klein 2012
  • Klein Klouwenberg PM, Ong DS, Bonten MJ, Cremer OL. Classification of sepsis, severe sepsis and septic shock: the impact of minor variations in data capture and definition of SIRS criteria. Intensive Care Medicine 2012;38(5):811-9. [PUBMED: 22476449]
Kuehn 2013
Kumar 2010
  • Kumar A. Early antimicrobial therapy in severe sepsis and septic shock. Current Infectious Disease Reports 2010;12(5):336-44. [PUBMED: 21308515]
Lagu 2012
  • Lagu T, Rothberg MB, Shieh MS, Pekow PS, Steingrub JS, Lindenauer PK. Hospitalizations, costs, and outcomes of severe sepsis in the United States 2003 to 2007. Critical Care Medicine 2012;40(3):754-61. [PUBMED: 21963582]
Levy 2003
  • Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et al. SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Medicine 2003;29(4):530-8. [PUBMED: 12664219]
Lichtenstern 2012
  • Lichtenstern C, Brenner T, Bardenheuer HJ, Weigand MA. Predictors of survival in sepsis: what is the best inflammatory marker to measure?. Current Opinion in Infectious Diseases 2012;25(3):328-36. [PUBMED: 22421751]
Machado 2013
  • Machado FR, Salomão R, Rigato O, Ferreira EM, Schettino G, Mohovic T, et al. Late recognition and illness severity are determinants of early death in severe septic patients. Clinics (Sao Paulo) 2013;68(5):586-91. [PUBMED: 23778420]
Maravić-Stojković 2011
  • Maravić-Stojković V, Lausević-Vuk L, Jović M, Ranković A, Borzanović M, Marinković J. Procalcitonin-based therapeutic strategy to reduce antibiotic use in patients after cardiac surgery: a randomized controlled trial. Srpski Arhiv za Celokupno Lekarstvo 2011;139(11-12):736-42. [PUBMED: 22338468]
Matthaiou 2012
  • Matthaiou DK, Ntani G, Kontogiorgi M, Poulakou G, Armaganidis A, Dimopoulos G. An ESICM systematic review and meta-analysis of procalcitonin-guided antibiotic therapy algorithms in adult critically ill patients. Intensive Care Medicine 2012;38(6):940-9. [PUBMED: 22538461]
McCann 2012
  • McCann FJ, Chapman SJ, Yu WC, Maskell NA, Davies RJ, Lee YC. Ability of procalcitonin to discriminate infection from non-infective inflammation using two pleural disease settings. PLoS One 2012;7(12):e49894. [PUBMED: 23251353]
Morgenthaler 2003
  • Morgenthaler NG, Struck J, Chancerelle Y, Weglöhner W, Agay D, Bohuon C, et al. Production of procalcitonin (PCT) in non-thyroidal tissue after LPS injection. Hormone and Metabolic Research 2003;35(5):290-5. [PUBMED: 12915998]
Redl 2000
  • Redl H, Schlag G, Tögel E, Assicot M, Bohuon C. Procalcitonin release patterns in a baboon model of trauma and sepsis: relationship to cytokines and neopterin. Critical Care Medicine 2000;28(11):3659-63. [PUBMED: 11098970]
RevMan 5.2 [Computer program]
  • The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012.
Rivers 2012
  • Rivers EP, Katranji M, Jaehne KA, Brown S, Abou Dagher G, Cannon C, et al. Early interventions in severe sepsis and septic shock: a review of the evidence one decade later. Minerva Anestesiologica 2012;78(6):712-24. [PUBMED: 22447123]
Rodger 2012
Salluh 2011
Salvo 1995
  • Salvo I, de Cian W, Musicco M, Langer M, Piadena R, Wolfler A, et al. The Italian SEPSIS study: preliminary results on the incidence and evolution of SIRS, sepsis, severe sepsis and septic shock. Intensive Care Medicine 1995;Suppl 2:S244-9. [PUBMED: 8636531]
Schuetz 2012
Shaikh 2011
  • Shaikh N, Evron J, Leeflang MM. Procalcitonin, C-reactive protein, and erythrocyte sedimentation rate for the diagnosis of acute pyelonephritis in children. Cochrane Database of Systematic Reviews 2011, Issue 6. [DOI: 10.1002/14651858.CD009185]
Silva 2004
Suresh 2013
  • Suresh G, Soll R. The diagnostic accuracy of C-reactive protein and procalcitonin for neonatal sepsis (registered Cochrane title). http://www.archie.cochrane.org/search.jsp Accessed January 31st 2014.
Tang 2007
  • Tang BM, Eslick GD, Craig JC, McLean AS. Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. The Lancet Infectious Diseases 2007;7(3):210-7. [PUBMED: 17317602]
Tang 2009
  • Tang H, Huang T, Jing J, Shen H, Cui W. Effect of procalcitonin-guided treatment in patients with infections: a systematic review and meta-analysis. Infection 2009;37(6):497-507. [PUBMED: 19826761]
Tasdelen 2010
  • Tasdelen Fisgin N, Aliyazicioglu Y, Tanyel E, Coban AY, Ulger F, Zivalioglu M, et al. The value of neopterin and procalcitonin in patients with sepsis. Southern Medical Journal 2010;103(3):216-9. [PUBMED: 20134373]
te Witt 2012
  • te Witt R, Hassing RJ, Petit PP, van Belkum A, van Genderen PJ. Procalcitonin and neopterin levels do not accurately distinguish bacterial from viral infections in ill-returned travellers with fever. Transactions of the Royal Society of Tropical Medicine and Hygiene 2012;106(4):264-6. [PUBMED: 22357400]
Tsalik 2012
  • Tsalik EL, Jaggers LB, Glickman SW, Langley RJ, van Velkinburgh JC, Park LP, et al. Discriminative value of inflammatory biomarkers for suspected sepsis. The Journal of Emergency Medicine 2012;43(1):97-106. [PUBMED: 22056545]
Uusitalo-Seppälä 2011
  • Uusitalo-Seppälä R, Koskinen P, Leino A, Peuravuori H, Vahlberg T, Rintala EM. Early detection of severe sepsis in the emergency room: diagnostic value of plasma C-reactive protein, procalcitonin, and interleukin-6. Scandinavian Journal of Infectious Diseases 2011;43(11-12):883-90. [PUBMED: 21892899]
Vaughan-Sarrazin 2011
  • Vaughan-Sarrazin MS, Bayman L, Cullen JJ. Costs of postoperative sepsis: the business case for quality improvement to reduce postoperative sepsis in veterans affairs hospitals. Archives of Surgery 2011;146(8):944-51. [PUBMED: 21502443]
Wacker 2013
  • Wacker C, Prkno A, Brunkhorst FM, Schlattmann P. Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis. The Lancet Infectious Diseases 2013;13(5):426-35. [PUBMED: 23375419]
Zannoni 2012
  • Zannoni A, Giunti M, Bernardini C, Gentilini F, Zaniboni A, Bacci ML, et al. Procalcitonin gene expression after LPS stimulation in the porcine animal model. Research in Veterinary Science 2012;93(2):921-7. [PUBMED: 22001598]